These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3892676)

  • 1. A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertension.
    Webb DJ; Hutcheson MJ; Robertson MP; Murray GD; Lorimer AR; Robertson JI
    Scott Med J; 1985 Apr; 30(2):106-10. PubMed ID: 3892676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urapidil and atenolol in hypertension.
    Török E; Wagner M; Podmaniczky M
    Drugs; 1988; 35 Suppl 6():164-72. PubMed ID: 3042356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
    Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P; Fagard R; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Lijnen P; Fagard R; Staessen J; Lissens W; Amery A
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):319-25. PubMed ID: 2476608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T; Westlie L; Daae L; Vatle S
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Lijnen P; Fagard R; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):461-6. PubMed ID: 2465447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of trimazosin and propranolol in essential hypertension.
    Helgeland A
    Am Heart J; 1983 Nov; 106(5 Pt 2):1253-8. PubMed ID: 6356854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a sustained-release formulation of trimazosin in mild to moderate hypertension.
    Byyny RL; Nies AS; LoVerde ME; Mitchell WD
    J Clin Pharmacol; 1987 Feb; 27(2):101-5. PubMed ID: 3680560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
    Johnson BF; Frishman WH; Brobyn R; Brown RD; Reeves RL; Wombolt DG
    Am J Hypertens; 1992 Oct; 5(10):727-32. PubMed ID: 1418836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
    Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of trimazosin: an effective and safe antihypertensive agent.
    Taylor CR; Leader JP; Singleton W; Munster EW; Falkner FC; O'Neil JA
    Am Heart J; 1983 Nov; 106(5 Pt 2):1269-81. PubMed ID: 6227228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study.
    Lischner M; Lang R; Jutrin I; Ravid M
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):43-6. PubMed ID: 3545737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
    López NC; Corral JL; Rincón LA; Arreaza MR; Giralt J; Galué GA; Barrios YE; Arocha I
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S101-5. PubMed ID: 1723446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.